Y-Intercept (HK)’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.77M | Buy |
+303,888
| New | +$2.77M | 0.07% | 459 |
|
2024
Q3 | – | Sell |
-22,094
| Closed | -$240K | – | 1744 |
|
2024
Q2 | $240K | Buy |
+22,094
| New | +$240K | 0.01% | 1107 |
|
2023
Q3 | – | Sell |
-8,774
| Closed | -$413K | – | 1522 |
|
2023
Q2 | $413K | Buy |
+8,774
| New | +$413K | 0.04% | 638 |
|
2023
Q1 | – | Sell |
-8,050
| Closed | -$307K | – | 1494 |
|
2022
Q4 | $307K | Buy |
+8,050
| New | +$307K | 0.05% | 647 |
|
2022
Q2 | – | Sell |
-9,265
| Closed | -$307K | – | 1151 |
|
2022
Q1 | $307K | Buy |
+9,265
| New | +$307K | 0.07% | 437 |
|
2021
Q1 | – | Sell |
-8,855
| Closed | -$785K | – | 777 |
|
2020
Q4 | $785K | Buy |
+8,855
| New | +$785K | 0.33% | 70 |
|